BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 6602640)

  • 1. Complement activation and generation of C3a anaphylatoxin by radiological contrast agents.
    Dawson P; Turner MW; Bradshaw A; Westaby S
    Br J Radiol; 1983 Jul; 56(667):447-8. PubMed ID: 6602640
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Angiography and complement activation. Evidence for generation of C3a anaphylatoxin by intravascular contrast agents.
    Westaby S; Dawson P; Turner MW; Pridie RB
    Cardiovasc Res; 1985 Feb; 19(2):85-8. PubMed ID: 3872180
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anaphylatoxin formation during hemodialysis: effects of different dialyzer membranes.
    Chenoweth DE; Cheung AK; Henderson LW
    Kidney Int; 1983 Dec; 24(6):764-9. PubMed ID: 6609269
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Complement activation and anaphylatoxin (C3a and C5a) formation in preeclampsia and by amniotic fluid.
    Haeger M; Bengtson A; Karlsson K; Heideman M
    Obstet Gynecol; 1989 Apr; 73(4):551-6. PubMed ID: 2784554
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anaphylatoxin generation in acute pancreatitis.
    Roxvall L; Bengtson A; Heideman M
    J Surg Res; 1989 Aug; 47(2):138-43. PubMed ID: 2787873
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Generation of C3a anaphylatoxin from human C3 by human mast cell tryptase.
    Schwartz LB; Kawahara MS; Hugli TE; Vik D; Fearon DT; Austen KF
    J Immunol; 1983 Apr; 130(4):1891-5. PubMed ID: 6339618
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The C terminus of the anaphylatoxin C3a generated upon complement activation represents a neoantigenic determinant with diagnostic potential.
    Burger R; Zilow G; Bader A; Friedlein A; Naser W
    J Immunol; 1988 Jul; 141(2):553-8. PubMed ID: 2454995
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anaphylatoxin generation in multisystem organ failure.
    Heideman M; Hugli TE
    J Trauma; 1984 Dec; 24(12):1038-43. PubMed ID: 6334754
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Generation of human C3a, C4a, and C5a anaphylatoxins by protein A of Staphylococcus aureus and immobilized protein A reagents used in serotherapy of cancer.
    Langone JJ; Das C; Bennett D; Terman DS
    J Immunol; 1984 Aug; 133(2):1057-63. PubMed ID: 6610702
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activation of complement by radiographic contrast media: generation of chemotactic and anaphylatoxin activities.
    Till G; Rother U; Gemsa D
    Int Arch Allergy Appl Immunol; 1978; 56(6):543-50. PubMed ID: 415989
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anaphylatoxin formation during hemodialysis: comparison of new and re-used dialyzers.
    Chenoweth DE; Cheung AK; Ward DM; Henderson LW
    Kidney Int; 1983 Dec; 24(6):770-4. PubMed ID: 6609270
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Complement activation during cardiopulmonary bypass: evidence for generation of C3a and C5a anaphylatoxins.
    Chenoweth DE; Cooper SW; Hugli TE; Stewart RW; Blackstone EH; Kirklin JW
    N Engl J Med; 1981 Feb; 304(9):497-503. PubMed ID: 7453783
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Generation and removal of anaphylatoxins during hemofiltration with five different membranes.
    Jørstad S; Smeby LC; Balstad T; Widerøe TE
    Blood Purif; 1988; 6(6):325-35. PubMed ID: 3264706
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased anaphylatoxins (C3a and C4a) in psoriatic sera.
    Ohkohchi K; Takematsu H; Tagami H
    Br J Dermatol; 1985 Aug; 113(2):189-96. PubMed ID: 3875363
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Generation of anaphylatoxin activity related to C3a, by treatment of human serum with the nitrogen nucleophile N2H4 or the chaotrope KSCN.
    von Zabern I; Damerau B; Nolte R; Grünefeld E; Vogt W
    Scand J Immunol; 1985 Dec; 22(6):639-51. PubMed ID: 3937227
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Complement activation produced by biomaterials.
    Chenoweth DE
    Artif Organs; 1988 Dec; 12(6):508-10. PubMed ID: 3265053
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dialysis leukopenia, hypoxemia, and anaphylatoxin formation: effect of membrane, bath, and citrate anticoagulation.
    Wiegmann TB; MacDougall ML; Diederich DA
    Am J Kidney Dis; 1988 May; 11(5):418-24. PubMed ID: 3259402
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activation of the third complement component (C3) and C3a generation in cardiac anaphylaxis: histamine release and associated inotropic and chronotropic effects.
    del Balzo U; Polley MJ; Levi R
    J Pharmacol Exp Ther; 1988 Sep; 246(3):911-6. PubMed ID: 2458450
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assays for plasma complement activation by x-ray contrast media.
    Eaton S; Tsay HM; Yost F; Tweedle MF
    Invest Radiol; 1990 Jul; 25(7):789-92. PubMed ID: 2391195
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anaphylatoxin generation and multisystem organ failure in acute pancreatitis.
    Roxvall L; Bengtson A; Heideman M
    Prog Clin Biol Res; 1989; 308():265-9. PubMed ID: 2789393
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.